Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
(NYSE:TEVA),(TASE:TEVA.TA),(TASE:TEVA), TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva“) announced today the pricing and early acceptance results of its previously announced tender offers (the “Offers“) to purchase for cash the outstanding notes issued by finance subsidiaries of Teva and guaranteed by Teva of the series […]